Intuit downgraded by Wolfe Research
Wolfe Research downgraded Intuit from Outperform to Peer Perform
- BTIG Research reiterated coverage on Abercrombie & Fitch with a new price target
BTIG Research reiterated coverage of Abercrombie & Fitch with a rating of Buy and set a new price target of $175.00 from $120.00 previously
- Qfin Holdings downgraded by Morgan Stanley with a new price target
Morgan Stanley downgraded Qfin Holdings from Overweight to Equal-Weight and set a new price target of $13.00
- FDA Tentative Approval for BEMPEDOIC ACID issued to DR. REDDY'S LABORATORIES LIMITED
Submission status for DR. REDDY'S LABORATORIES LIMITED's drug BEMPEDOIC ACID (ORIG-1) with active ingredient BEMPEDOIC ACID has changed to 'Tentative Approval' on 08/06/2026. Application Category: ANDA, Application Number: 219312, Application Classification:
- Qfin Holdings downgraded by Citigroup with a new price target
Citigroup downgraded Qfin Holdings from Buy to Sell and set a new price target of $8.00
- EOG Resources downgraded by CapitalOne with a new price target
CapitalOne downgraded EOG Resources from Overweight to Equal Weight and set a new price target of $153.00
- Qfin Holdings downgraded by Analyst with a new price target
Analyst downgraded Qfin Holdings from Neutral to Underweight and set a new price target of $9.00
- Craig Hallum initiated coverage on York Space Systems with a new price target
Craig Hallum initiated coverage of York Space Systems with a rating of Hold and set a new price target of $11.00
- The Benchmark Company initiated coverage on Lattice Semi with a new price target
The Benchmark Company initiated coverage of Lattice Semi with a rating of Buy and set a new price target of $160.00
- Jefferies resumed coverage on L3Harris with a new price target
Jefferies resumed coverage of L3Harris with a rating of Hold and set a new price target of $315.00
- RBC Capital Mkts initiated coverage on JFrog with a new price target
RBC Capital Mkts initiated coverage of JFrog with a rating of Outperform and set a new price target of $118.00
- Wolfe Research initiated coverage on Harmony Biosciences with a new price target
Wolfe Research initiated coverage of Harmony Biosciences with a rating of Outperform and set a new price target of $60.00
- Needham initiated coverage on Evommune with a new price target
Needham initiated coverage of Evommune with a rating of Buy and set a new price target of $28.00
- B. Riley Securities initiated coverage on Cardiol Therapeutics with a new price target
B. Riley Securities initiated coverage of Cardiol Therapeutics with a rating of Buy and set a new price target of $11.00
- Truist initiated coverage on AxoGen with a new price target
Truist initiated coverage of AxoGen with a rating of Buy and set a new price target of $60.00
- RBC Capital Mkts initiated coverage on Atlassian with a new price target
RBC Capital Mkts initiated coverage of Atlassian with a rating of Outperform and set a new price target of $215.00
- Daiwa Securities initiated coverage on ACM Research with a new price target
Daiwa Securities initiated coverage of ACM Research with a rating of Buy and set a new price target of $136.00
- Trupanion downgraded by Piper Sandler with a new price target
Piper Sandler downgraded Trupanion from Overweight to Neutral and set a new price target of $32.00
- TJX downgraded by Jefferies with a new price target
Jefferies downgraded TJX from Buy to Hold and set a new price target of $145.00